Verona Pharma Plc - ADR
VRNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.16B
Close$
$35.19
67.1% downside
Current Fair Value
67.1% downsideOvervalued by 67.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.16 Billion |
|---|---|
| Enterprise Value | $8.96 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.68 |
| Beta | 0.05 |
| Outstanding Shares | 85,644,897 |
Return
| Return on Equity | -29.18% |
|---|---|
| Return on Assets | -14.17% |
| Return on Invested Capital | -21.24% |
Valuation & Multiples
| P/E Ratio | -63.64 |
|---|---|
| PEG | 54.47 |
| Price to Sales | 53.46 |
| Price to Book Ratio | 35.64 |
| Enterprise Value to Revenue | 40.43 |
| Enterprise Value to EBIT | -80.88 |
| Enterprise Value to Net Income | -111 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.88 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7014▼ 265.45% |
|---|---|
| Total Calls | 638,600▼ 29.17% |
| Total Puts | 447,912▼ 85.20% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 93.93%▲ 82.75% |
|---|---|
| Total Invested | $8.58B▲ 19.54% |
| Investors Holding | 268▼ 46.00% |
ESG Score
No data
About Verona Pharma Plc
CEO: David Zaccardelli